Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
2965 |
|
Actual shortage: | 229 (8%) | |
Anticipated shortage: | 27 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2700 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
25 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-HYDROMORPHONE | 8MG | TABLET | Resolved | 2021-11-12 | 2021-12-20 | 149167 |
APO-HYDROMORPHONE | 2MG | TABLET | Resolved | 2022-02-04 | 2022-02-22 | 154175 |
APO-HYDROMORPHONE | 8MG | TABLET | Resolved | 2023-06-09 | 2023-10-15 | 194587 |
APO-HYDROMORPHONE | 2MG | TABLET | Resolved | 2023-09-01 | 2023-09-28 | 203548 |
APO-HYDROMORPHONE | 4MG | TABLET | Resolved | 2023-09-07 | 2023-11-06 | 203852 |
APO-HYDROMORPHONE | 1MG | TABLET | Resolved | 2023-10-27 | 2023-12-15 | 208397 |
APO-HYDROMORPHONE | 2MG | TABLET | Resolved | 2023-12-01 | 2024-01-12 | 212383 |
APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Resolved | 2023-11-10 | 2023-11-17 | 209942 |
APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Actual shortage | 2024-03-22 | 2024-03-22 | 223083 |
APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Resolved | 2017-07-25 | 2017-09-15 | 16931 |
APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Resolved | 2017-10-11 | 2018-03-06 | 25210 |
APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Resolved | 2018-12-12 | 2019-01-17 | 69302 |
APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Resolved | 2019-03-05 | 2019-03-29 | 77887 |
APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Resolved | 2020-09-02 | 2020-09-09 | 123566 |
APO-HYDRALAZINE | 25MG | TABLET | Resolved | 2017-08-03 | 2017-10-10 | 18184 |
APO-HYDRALAZINE | 50MG | TABLET | Resolved | 2017-08-03 | 2017-10-10 | 18187 |
APO-HYDRALAZINE | 10MG | TABLET | Resolved | 2017-08-03 | 2017-10-10 | 18190 |
APO-HYDRALAZINE | 25MG | TABLET | Resolved | 2019-11-20 | 2019-11-25 | 99299 |
APO-HYDRALAZINE | 50MG | TABLET | Resolved | 2019-11-20 | 2019-11-25 | 99304 |
APO-HYDRALAZINE | 25MG | TABLET | Resolved | 2019-12-12 | 2020-01-07 | 101094 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |